[RCUS] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY-
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 112,000 382,882 77,517 15,000 8,353 1,413 0 -
PBT -266,000 54,645 -122,858 -84,710 -49,594 -53,082 -17,970 56.66%
Tax 1,000 1,815 -6,181 -8,779 5,265 0 0 -
NP -267,000 53,000 -116,677 -75,931 -49,594 -53,082 -17,970 56.76%
Tax Rate - -3.32% - - - - - -
Total Cost 379,000 329,882 194,194 90,931 57,947 54,495 17,970 66.18%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -238.39 13.84 -150.52 -506.21 -593.73 -3,756.69 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -3.71 0.76 -2.13 -1.73 -1.43 -1.25 -0.73 31.10%
EPS Diluted -3.71 0.71 -2.13 -1.73 -1.43 -1.25 -0.73 31.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.